Kodiak Sciences Inc

NASDAQ:KOD

3.28

+0.10 (+2.98%)

6:14:33 PM EDT: $3.30 +0.02 (+0.61%)

Kodiak Sciences Inc Stock, NASDAQ:KOD

1200 Page Mill Road, Palo Alto, California 94304

United States of America

Phone: +1.650.281.0850

Number of Employees: 111

http://www.kodiak.com

Description

Kodiak Sciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the research, development, and commercialization of therapeutics for retinal diseases. Its product pipeline includes KSI-301 for wet AMD, KSI-301 for diabetic eye disease, KSI-501 for DME and uveitis, KSI-201 for resistant wet AMD, and KSI-401 for dry AMD. The company was founded by Stephen A. Charles and Victor Perlroth in 2009 and is headquartered in Palo Alto, CA.